Feb. 11, 2025  — UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound, recently announced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM).

Cardiac ultrasound is routinely used as an essential tool in the diagnosis and management of oHCM.

Feb. 13, 2025 — Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is helping to provide more treatment options to people living with tricuspid valve disease..

Feb. 10, 2025 — A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio. Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.

The Houston Aortic Symposium 2025

Feb. 12, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, recently made an oral presentation of data on the benefits of atrioventricular interval modulation (AVIM) therapy on patients with diastolic dysfunction at the Technology and Heart Failure Therapeutics (THT) 2025 Conference in Boston, Mass.

Feb. 14, 2025 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, has published the TAILORED-AF clinical trial in Nature Medicine, which demonstrated that an AI-guided procedure for persistent atrial fibrillation (AF) in combination with conventional pulmonary vein isolation (PVI) treatment, resulted in better outcomes than PVI alone.

Feb. 12, 2025 — On Feb. 11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., cardiac electrophysiologist, performed one of the nation’s first procedures to control atrial fibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy — or ablation — to destroy the damaged part of the heart that is triggering the abnormal heartbeats. It does this without harming any of the heart’s healthy tissue. Destroying the damaged tissue helps restore the heart’s regular rhythm.

Feb. 6, 2025 — Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, recently announced publication of a peer-reviewed study evaluating its novel algorithm for the detection of pulmonary hypertension (PH).

The study, which was published in the Journal of the American Heart Association (JAHA), highlighted the algorithm’s ability to analyze heart sounds recorded with a digital stethoscope for identifying elevated pulmonary artery systolic pressures, a key indicator of PH.

Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw fewer referrals to cardiology, and were prescribed less frequent post-stroke cardiac monitoring than men when admitted to comprehensive stroke centers following stroke. The data were presented at the International Stroke Conference (ISC) in Los Angeles.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now